Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 8.1 Exhibit 8.1
- 8.2 Exhibit 8.2
- 10.25 Exhibit 10.25
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.30 Exhibit 10.30
- 10.31 Exhibit 10.31
- 10.32 Exhibit 10.32
- 10.33 Exhibit 10.33
- 10.34 Exhibit 10.34
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- 99.6 Exhibit 99.6
- 99.7 Exhibit 99.7
- 99.8 Exhibit 99.8
- 99.9 Exhibit 99.9
- Download Excel data file
- View Excel data file
Associated filings
- 1 May 23 EFFECT Notice of effectiveness
- 28 Apr 23 424B3 Prospectus supplement
- 26 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
29 Mar 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 Feb 23 S-4 Registration of securities issued in business combination transactions
ELTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 1 to the Registration Statement on Form S-4 (No. 333-269741) of Angion Biomedica Corp. (the “Company”), of our report dated March 17, 2023, relating to the consolidated financial statements of the Company. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Moss Adams LLP
San Francisco, California
March 29, 2023